ST

Seaport Therapeutics

MA - Boston
Biotechnology1 H-1B visas (FY2023)

Focus: Neuro Discovery Platform

Seaport Therapeutics is a life sciences company focused on Neuro Discovery Platform.

PsychiatryMetabolic Diseases
Open Jobs
6

Pipeline & Clinical Trials

Clinical Trials (1)
NCT07065240A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Phase 2
Clinical Trials (1)
NCT07161700An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
Phase 2

Open Jobs (6)

Interview Prep Quick Facts
Portfolio: 2 clinical trials
H-1B (2023): 1 approval
Publications: 3 in PubMed
Open Roles: 6 active jobs

Hiring Trend

Stable
6
Open Roles
+1
Added
-1
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub